Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (62)	5/31/1997 6:53:00 PM
From: Peter Silsbee	of 186

RH said: "If you feel that biotech patents are murky and difficult to enforce, why are you investing in the sector? Patents are all we've got." Here's one view of the question, from the SNAP 1996 annual report: "Patent law as it relates to inventions in the biotechnology field is still evolving, and involves complex legal and factual questions for which legal principles are not firmly established." Regarding the statement that 'Microcide and their partners reportedly have "the largest dedicated antibiotic research effort in the world,"' something like this statement appears in MCDE's annual report : "Microcide today, together with its corporate partners, is engaged in the largest antibiotic research and development effort in the world." To anyone: surely, resistant bacteria such as those targeted by MCDE are an obvious focus area, and have been for years (the recent "news" about resistant strains is hardly unexpected). What other major efforts are under way in this area? What is the competition? Here is one (follow link and search for "staph"), which seems to be in pretty early stages. merck.com!!svpsW1FF_svptL3T3k/mrl/speakerlist/ms003.html PLS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next